• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Lescarden Inc

+ Add to Watchlist

LCAR:US

0.0250 USD 0.00000.00%

As of 12:20:44 ET on 09/23/2014.

Snapshot for Lescarden Inc (LCAR)

Open: 0.0220 Day's Range: 0.0220 - 0.0250 Volume: 61,300
Previous Close: 0.0250 52wk Range: 0.0174 - 0.0900 1-Yr Rtn: -50.00%

Stock Chart for LCAR

No chart data available.
  • LCAR:US 0.0250
  • 1D
  • 1M
  • 1Y
0.0250
Interactive LCAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LCAR

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0032
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 1.59
Shares Outstanding (M) 63.62
30 Day Average Volume 2,417
Price/Book (mrq) -
Price/Sale (ttm) 3.0603
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LCAR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LCAR

Lescarden Inc. researches, develops, and tests medications for the treatment of diseases. The Company's products, which are used to treat cancer, non-healing wounds, and inflammatory joint diseases, include Catrix, Bio-Cartilage, and Poly-NAG.

William E LutherPresident/CEO/CFO
More Company Profile & Key Executives for LCAR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil